the B-UP AlfaSigma deal is the only real action that is happening
Untrue. We will be running a B-UC oral phase 2 with the money we have if COVID fails.
B-UP is worth $6M ($1M P3 start, $1M P3 finish, $1M NDA Submission, $3M NDA approval) in milestones and a 2% royalty with their reformulation if I am not mistaken. If they hit $100M/$200M/$300M in sales we get a fixed milestone payment of $3M/$6M/$9M. It is effectively worthless to us until it is approved.
They money from that deal is not enough to sustain our current market cap.